Abituzumab Withdrawn Phase 2 Trials for Metastatic Colorectal Cancer (CRC) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03688230 | Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer. |